Literature DB >> 21080999

Differences in access and patient outcomes across antiretroviral treatment clinics in the Free State province: a prospective cohort study.

Suzanne M Ingle1, Margaret May, Kerry Uebel, Venessa Timmerman, Eduan Kotze, Max Bachmann, Jonathan A C Sterne, Matthias Egger, Lara Fairall.   

Abstract

OBJECTIVE: To assess differences in access to antiretroviral treatment (ART) and patient outcomes across public sector treatment facilities in the Free State province, South Africa.
DESIGN: Prospective cohort study with retrospective database linkage. We analysed data on patients enrolled in the treatment programme across 36 facilities between May 2004 and December 2007, and assessed percentage initiating ART and percentage dead at 1 year after enrolment. Multivariable logistic regression was used to estimate associations of facility-level and patient-level characteristics with both mortality and treatment status.
RESULTS: Of 44 866 patients enrolled, 15 219 initiated treatment within 1 year; 8 778 died within 1 year, 7 286 before accessing ART. Outcomes at 1 year varied greatly across facilities and more variability was explained by facility-level factors than by patient-level factors. The odds of starting treatment within 1 year improved over calendar time. Patients enrolled in facilities with treatment initiation available on site had higher odds of starting treatment and lower odds of death at 1 year compared with those enrolled in facilities that did not offer treatment initiation. Patients were less likely to start treatment if they were male, severely immunosuppressed (CD4 count ≤50 cells/µl), or underweight (<50 kg). Men were also more likely to die in the first year after enrolment.
CONCLUSIONS: Although increasing numbers of patients started ART between 2004 and 2007, many patients died before accessing ART. Patient outcomes could be improved by decentralisation of treatment services, fast-tracking the most immunodeficient patients and improving access, especially for men.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21080999      PMCID: PMC3059232          DOI: 10.7196/samj.3952

Source DB:  PubMed          Journal:  S Afr Med J


  21 in total

1.  Initial burden of disease estimates for South Africa, 2000.

Authors:  Debbie Bradshaw; Pam Groenewald; Ria Laubscher; Nadine Nannan; Beatrice Nojilana; Rosana Norman; Desiréé Pieterse; Michelle Schneider; David E Bourne; Ian M Timaeus; Rob Dorrington; Leigh Johnson
Journal:  S Afr Med J       Date:  2003-09

2.  Making universal access a reality--what more do we need to know?

Authors:  Lisa R Hirschhorn; Richard Skolnik
Journal:  J Infect Dis       Date:  2008-05-01       Impact factor: 5.226

3.  South African cause-of-death profile in transition--1996 and future trends.

Authors:  Debbie Bradshaw; Michelle Schneider; Rob Dorrington; David E Bourne; Ria Laubscher
Journal:  S Afr Med J       Date:  2002-08

4.  Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls.

Authors:  Jonathan A C Sterne; Ian R White; John B Carlin; Michael Spratt; Patrick Royston; Michael G Kenward; Angela M Wood; James R Carpenter
Journal:  BMJ       Date:  2009-06-29

5.  Estimation of adult antiretroviral treatment coverage in South Africa.

Authors:  Muhammad Aarif Adam; Leigh F Johnson
Journal:  S Afr Med J       Date:  2009-09

6.  Public-sector ART in the Free State Province, South Africa: community support as an important determinant of outcome.

Authors:  Edwin Wouters; Wim Van Damme; Francis Van Loon; Dingie van Rensburg; Herman Meulemans
Journal:  Soc Sci Med       Date:  2009-08-18       Impact factor: 4.634

7.  Adult mortality and antiretroviral treatment roll-out in rural KwaZulu-Natal, South Africa.

Authors:  Abraham J Herbst; Graham S Cooke; Till Bärnighausen; Angelique KanyKany; Frank Tanser; Marie-Louise Newell
Journal:  Bull World Health Organ       Date:  2009-10       Impact factor: 9.408

8.  Loss to care and death before antiretroviral therapy in Durban, South Africa.

Authors:  Ingrid V Bassett; Bingxia Wang; Senica Chetty; Matilda Mazibuko; Benjamin Bearnot; Janet Giddy; Zhigang Lu; Elena Losina; Rochelle P Walensky; Kenneth A Freedberg
Journal:  J Acquir Immune Defic Syndr       Date:  2009-06-01       Impact factor: 3.731

9.  Effectiveness of antiretroviral treatment in a South African program: a cohort study.

Authors:  Lara R Fairall; Max O Bachmann; Goedele M C Louwagie; Cloete van Vuuren; Perpetual Chikobvu; Dewald Steyn; Gillian H Staniland; Venessa Timmerman; Mpumelelo Msimanga; Chris J Seebregts; Andrew Boulle; Ralph Nhiwatiwa; Eric D Bateman; Merrick F Zwarenstein; Ronald D Chapman
Journal:  Arch Intern Med       Date:  2008-01-14

Review 10.  Provision of antiretroviral therapy in South Africa: unique challenges and remaining obstacles.

Authors:  Bisola Ojikutu; Chris Jack; Gita Ramjee
Journal:  J Infect Dis       Date:  2007-12-01       Impact factor: 5.226

View more
  10 in total

1.  Outcomes in patients waiting for antiretroviral treatment in the Free State Province, South Africa: prospective linkage study.

Authors:  Suzanne M Ingle; Margaret May; Kerry Uebel; Venessa Timmerman; Eduan Kotze; Max Bachmann; Jonathan A C Sterne; Matthias Egger; Lara Fairall
Journal:  AIDS       Date:  2010-11-13       Impact factor: 4.177

2.  Dying in their prime: determinants and space-time risk of adult mortality in rural South Africa.

Authors:  Benn Sartorius; Kathleen Kahn; Mark A Collinson; Kurt Sartorius; Stephen M Tollman
Journal:  Geospat Health       Date:  2013-05       Impact factor: 1.212

3.  Economic evaluation of task-shifting approaches to the dispensing of anti-retroviral therapy.

Authors:  Nicola Foster; Diane McIntyre
Journal:  Hum Resour Health       Date:  2012-09-13

Review 4.  Engaging men in prevention and care for HIV/AIDS in Africa.

Authors:  Edward J Mills; Chris Beyrer; Josephine Birungi; Mark R Dybul
Journal:  PLoS Med       Date:  2012-02-07       Impact factor: 11.069

5.  Risk factors for loss to follow-up prior to ART initiation among patients enrolling in HIV care with CD4+ cell count ≥200 cells/μL in the multi-country MTCT-Plus Initiative.

Authors:  R Charon Gwynn; Ashraf Fawzy; Ida Viho; Yingfeng Wu; Elaine J Abrams; Denis Nash
Journal:  BMC Health Serv Res       Date:  2015-06-25       Impact factor: 2.655

6.  Development of a National Campaign Addressing South African Men's Fears About HIV Counseling and Testing and Antiretroviral Treatment.

Authors:  Neil Orr; Helen Hajiyiannis; Laura Myers; Mzamani Benjamin Makhubele; Tselisehang Matekane; Richard Delate; Lusanda Mahlasela; Brenda Goldblatt
Journal:  J Acquir Immune Defic Syndr       Date:  2017-01-01       Impact factor: 3.731

7.  The costs of providing antiretroviral therapy services to HIV-infected individuals presenting with advanced HIV disease at public health centres in Dar es Salaam, Tanzania: Findings from a randomised trial evaluating different health care strategies.

Authors:  Godfather Dickson Kimaro; Sayoki Mfinanga; Victoria Simms; Sokoine Kivuyo; Christian Bottomley; Neil Hawkins; Thomas S Harrison; Shabbar Jaffar; Lorna Guinness
Journal:  PLoS One       Date:  2017-02-24       Impact factor: 3.240

8.  Clinical mentoring to improve quality of care provided at three NIM-ART facilities: A mixed methods study.

Authors:  Chris A Visser; Jacqueline E Wolvaardt; David Cameron; Gert J O Marincowitz
Journal:  Afr J Prim Health Care Fam Med       Date:  2018-06-14

9.  Assessment of service quality of public antiretroviral treatment (ART) clinics in South Africa: a cross-sectional study.

Authors:  Hans F Kinkel; Adeboye M Adelekan; Tessa S Marcus; Gustaaf Wolvaardt
Journal:  BMC Health Serv Res       Date:  2012-07-31       Impact factor: 2.655

10.  Missed opportunities for retention in pre-ART care in Cape Town, South Africa.

Authors:  Elizabeth du Toit; Cari van Schalkwyk; Rory Dunbar; Karen Jennings; Blia Yang; David Coetzee; Nulda Beyers
Journal:  PLoS One       Date:  2014-05-07       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.